Commodore Capital
Commodore Capital is a New York-based venture capital firm founded in 2019, focused on investing in the healthcare, pharmaceutical, and biotechnology sectors. The firm targets minority investments in companies at various stages, including seed-stage and early-stage ventures. With a keen interest in the biopharmaceutical industry, Commodore Capital aims to capitalize on the early phases of significant innovation cycles within this field. As a Registered Investment Adviser, the firm is equipped to navigate the complexities of the investment landscape while fostering the growth of emerging companies in its chosen sectors.
SAb Biotherapeutics
Post in 2023
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical development company based in Sioux Falls, South Dakota, with an additional office in Cambridge, Massachusetts. Founded in 2014, the company focuses on developing immunotherapies for various human diseases using its proprietary DiversitAb platform. This innovative platform enables the rapid production of fully targeted human polyclonal antibodies from genetically engineered transchromosomic cattle, eliminating the need for human plasma or serum. SAB Biotherapeutics' product pipeline includes SAB-142 for Type 1 diabetes, SAB-176 for seasonal influenza, and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The company's approach aims to address public health challenges, rare diseases, and pandemic threats through advanced antibody science.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.